DISCOVISC

This brand name is authorized in Ecuador, Japan, South Africa

Active ingredients

The drug DISCOVISC contains a combination of these active pharmaceutical ingredients (APIs):

1 Sodium chondroitin sulfate UNII 6IC1M3OG5Z - CHONDROITIN SULFATE (BOVINE)

Chondroitin sulfate belongs to the polysaccharide subgroup of glycosaminoglycans. Chondroitin sulfate is one of the main elements of the cartilage, which joins a central protein, forming what we know as proteoglycan, which is what gives the cartilage its mechanical and elastic properties. Read about Chondroitin sulfate

2 Hyaluronate sodium UNII YSE9PPT4TH - HYALURONATE SODIUM

Read about Hyaluronate sodium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01KA51	Hyaluronic acid, combinations	S Sensory organs → S01 Ophthalmologicals → S01K Surgical aids → S01KA Viscoelastic substances
Discover more medicines within S01KA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.993-12-08
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319818Q1025
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/3/0404